Massachusetts Institute of Technology Massachusetts Institute of Technology
Department of Chemical Engineering
Langer Lab
Symposium Chairmen
Abstract Submission
Hotel Information

US - Japan Symposium on Drug Delivery Systems

2013 Speakers

Toshihiko Amanuma
Scientist, 3-D Matrix, Inc.
Expanding universe of self-assembling peptides

Mark Bagarazzi
Chief Medical Officer, Inovio Pharmaceuticals, Inc.
Developing immunotherapeutic approaches to cancer and …

Rick Batycky
Chief Scientific Officer, Civitas Therapeutics
Inhaled Levodopa: A novel solution to debilitating “OFF” episodes in Parkinson’s Disease

Henry Brem
Neurosurgeon-in-Chief and Harvey Cushing Professor, Johns Hopkins School of Medicine
Advances in brain tumor therapy  

Hongming Chen
Vice President of Research, Kala Pharmaceuticals
Mucus penetrating particles for ophthalmic applications

Joseph DeSimone

Chancellor’s Eminent Professor of Chemistry, University of North Carolina - Chapel Hill; Kenan, Jr. Professof or Chemical Engineering at North Carolina State University
The PRINT particle platform:  Synthetic blood, therapeutics and vaccines

Robert Farra
President and Chief Operating Officer MicroCHIPS, Inc
First in man trial of a drug delivery microchip

David Giljohann
Chief Operating Officer, AuraSense Therapeutics LLC

Jeff Hrkach
Senior Vice President, Research and Development, BIND Biosciences, Inc
BIND accurins: Targeted and programmable nanomedicines

Mark Iwicki
President and Chief Executive Officer, Blend Therapeutics

Lloyd Johnston
Vice President, Pharmaceutical Research and Development, Selecta Biosciences
Engineered nanoparticles for novel immunotherapies

Yasushi Kaneda
Professor, Division of Gene Therapy Science, Graduate School of Medicine, Osaka University
Molecular mechanism of recruiting bone marrow-derived mesenchymal stem cells to injured area

Kazunori Kataoka
Professor, Department of Materials Engineering, Graduate School of Engineering, University of Tokyo
Smart supramolecular nanostructures from block copolymers for gene and drug delivery

Sung Wan Kim
Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry and Bioengineering
Polymeric gene delivery for the treatment of myocardial infarct

Hiromu Kondo
Senior Director, Drug Delivery, Pharmaceutical Research and Technology Labs, Astellas Pharma Inc.
Pharmaceutical approach to reduce the food-effect on oral bioavailability

Martin Maier
Senior Director, Drug Discovery, Alnylam Pharmaceuticals
Advances in systemic delivery of RNAi therapeutics

Naoki Makita
Scientist, DDS Research Group, Formulation Research & Development Laboratories, Technology Research & Development, Dainippon Sumitomo Pharma Co., Ltd.
Local application of siRNA formulated with atelocollagen

Akira Marui
Associate Professor, Department of Cardiovascular Surgery, Kyoto University Hospital
Biomaterial-based regenerative therapy in cardiovascular field

Chad Mirkin
Rathman Professor of Chemistry, Northwestern University

Milan Mrkisch
Henry Wade Rogers Professor, Northwestern University
The counter intuitive side of epigenic targets

Willem Mulder
Associate Professor, Mt. Sinai School of Medicine

Masaya Nakamura
Associate professor, Department of Orthopedic Surgery, School of Medicine, Keio University
Regenerative medicine for spinal cord injury

Teruo Okano
Vice President and Professor, Institute of Advanced Biomedical Engineering and Science
Tokyo Women's Medical University
Reconstruction of 3D tissue and organ for drug screening model

Maria Palasis
Executive Vice President and Chief Technology Officer, 480 Biomedical

John Patton
President and Chief Executive Officer, Dance Pharmaceuticals
Inhaled insulin:  Still compelling

Purnanand Sarma
President and CEO of TARIS Biomedical
Controlled delivery to urinary bladder

Francis Szoka
Professor of Biopharmaceutical Sciences, University of California - San Francisco
Engineering lipids and liposomes for targeted anticancer drug therapy

Nobuyuki Takakura
Professor, Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University
Regulation of angiogenesis in vascular diseases

Hideki Taniguchi, Professor
Takanori Takebe, Scientist
Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine
Vascularised and functional human liver from an iPSC-derived organ bud transplant

C. Shad Thaxton
Assistant Professor, Northwestern University, Feinberg School of Medicine
Biomimetic nanoparticles as cancer therapy and for drug delivery

Fumiyoshi Yamashita
Associate Professor, Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University
In silico pharmacokinetics For efficient drug discovery and development

Jonathan Zheng Zhang
Principal Scientist, Semprus BioSciences
Betaine modifications for medical devices


Langer Lab, 77 Massachusetts Ave, Room 76-661, Cambridge, MA 02139-4307 | Phone: 617.253.3123 | Last updated: May 29, 2014